Home
Scholarly Works
In patients hospitalized for COVID-19, tocilizumab...
Journal article

In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d.

Abstract

SOURCE CITATION: WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Shankar-Hari M, Vale CL, Godolphin PJ, et al. Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis. JAMA. 2021;326:499-518. 34228774.

Authors

Lo CKL; Chagla Z

Journal

Annals of Internal Medicine, Vol. 174, No. 11,

Publisher

American College of Physicians

Publication Date

November 1, 2021

DOI

10.7326/acpj202111160-125

ISSN

1056-8751

Associated Experts

Zain Chagla

Associate Professor, Faculty of Health Sciences
Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences3202 Clinical Sciences

Sustainable Development Goals (SDG)

3 Good Health and Well Being

Medical Subject Headings (MeSH)

Antibodies, Monoclonal, HumanizedHumansSARS-CoV-2COVID-19 Drug Treatment
View published work (Non-McMaster Users)
View published work (McMaster Users)

Contact the Experts team

Get technical help
or
Provide website feedback